Goldshield settles £1m 'price-fixing' claim
Thursday 06 March 2008
The drug company Goldshield, which is accused of fixing the price of medicines supplied to the NHS, has agreed to pay £1m to settle claims brought by the health authorities of Northern Ireland and Scotland.
Without admission of liability and on a "full and final basis", Goldshield yesterday agreed to pay £250,000 to the Department of Health and Social Services of Northern Ireland, a day after settling its claim with the Scottish authorities for £750,000.
The move comes eight months after the company paid the NHS £4m to settle its claims relating to the price-fixing of generic medicine bringing the total paid out by the company to £5m.
The civil claims accused a number of drug companies of operating a cartel and colluding to fix the price of warfarin, a blood-thinning drug.
Keith Hellawell, chairman of Goldshield, said he was pleased to have reached a settlement with the different authorities. "We recognise the importance of building strong working relationships with our customers," he said.
The Scottish Health Secretary Nicola Sturgeon said: "I am delighted we have managed to reach a settlement agreement with Goldshield. This is a satisfactory conclusion to our negotiations."
Shares in the company rose 4.5p yesterday to 274p.
The Serious Fraud Office (SFO) is continuing with its criminal investigation relating to allegations concerning warfarin and penicillin-based antibiotics supplied to the NHS between January 1996 and December 2000. As part of an inquiry into the alleged multimillion-pound scam, police raided six drug companies in 2002.
The company's former chief executive and co-founder, Ajit Patel, and Kirti Patel, chief operating officer, resigned from the company last summer to focus on the criminal case and former finance director Rakesh Patel became chief executive.
At the time of the company's interim results in September, Dr Hellawell said Goldshield remained in positive dialogue with the SFO. If the case were to end in a trial, Goldshield could face a fine of £5m to £6m if found guilty, according to analysts.
The group reported half-year pre-tax profit of £6.1m in September compared with losses of £3.6m the same period the previous year. The company has changed its strategy to focus on its core pharmaceutical and healthcare business after agreeing to sell off its India business.
- 1 Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
- 2 Christians: The world's most persecuted people
- 3 The secret report that helps Israelis to hide facts
- 4 Danish TV reporter is all business up top, all party down below
- 5 Denmark bans kosher and halal slaughter as minister says ‘animal rights come before religion’
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
Israel-Gaza conflict: The children were playing in the street with toy guns. The air strikes were tragically real
Danish TV reporter is all business up top, all party down below
Syria conflict: Syrian and Turkish Kurds unite to battle Isis threat - ‘We shoot them like sheep, but next day double the number return’
Ross Burden dead: MasterChef and Ready Steady Cook star, dies aged 45
The secret report that helps Israelis to hide facts
A day in the life of Vladimir Putin: The dictator in his labyrinth
A new Russian revolution: The cracks are starting to appear in Putin’s Kremlin power bloc
Were 'Poor Doors' added to mixed developments so wealthy residents don't have to go in alongside social housing tenants?
Arizona execution lasts two hours as killer Joseph Wood left 'snorting and gasping' for air
Opponents of Israel's military operation in Gaza are the real enemies of Middle Eastern peace
iJobs Money & Business
Data Governance Manager (Solvency II) – Contract – Up to £450 daily rate, 6 month (may go Permanent)
£350 - £450 Per Day: Clearwater People Solutions Ltd: We are currently looking...
£500 - £560 per day: Orgtel: Java Developer FX - Banking - London - Up to £560...
£350 - £400 per day + competitive: Orgtel: My client, a leading bank, is curre...
£26000 - £30000 per annum + Benefits: Ashdown Group: Account Manager - (Produc...